The patented STEP-Technology is applied for the in-situ characterization of particle properties and the direct characterization of the physical formulation stability of adjuvants and vaccines.
Real-time, real-condition stability studies and the accelerated stability studies are discussed on the basis of the WHO Guidelines.
A redispersibility case study on aluminum-containing adjuvants is complemented with information on particle and aggregate sizing, nano particle adsorption and applications related to influenza.
Learn how LUMiReader PSA and LUMiSizer let you follow our slogan: The Next STEP in Dispersion Analysis and Materials Testing.
DATE: 25 June 2020, 9-10 am (UTC 7-8 am)
DATE: 25 June 2020, 4-5 pm (UTC 2-3 pm)
Telefon: +49 (30) 6780-6058
Telefax: +49 (30) 6780-6030
Sales & Marketing Manager
Telefon: +49 (30) 678060-40
Fax: +49 (40) 678060-58